切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2022, Vol. 18 ›› Issue (04) : 419 -426. doi: 10.3877/cma.j.issn.1673-5250.2022.04.007

论著

极早产儿支气管肺发育不良影响因素的多中心临床研究
刘燕1,(), 赵铭1, 姜红1, 陈晨2, 王小琴3, 张磊4   
  1. 1青岛大学附属医院儿童医学中心新生儿科,青岛 266003
    2济宁市第一人民医院新生儿科,济宁 272002
    3青岛市市立医院儿科,青岛 266071
    4枣庄市妇幼保健院新生儿科,枣庄 261031
  • 收稿日期:2021-12-11 修回日期:2022-06-08 出版日期:2022-08-01
  • 通信作者: 刘燕

Risk factors of bronchopulmonary dysplasia in very preterm infants: a multicenter study

Yan Liu1,(), Ming Zhao1, Hong Jiang1, Chen Chen2, Xiaoqin Wang3, Lei Zhang4   

  1. 1Department of Neonatology, Children′s Medical Center, The Affiliated Hospital of Qingdao University, Qingdao 266003, Shandong Province, China
    2Department of Neonatology, Jining No.1 People′s Hospital, Jining 272002, Shandong Province, China
    3Department of Pediatrics, Qingdao Municipal Hospital, Qingdao 266071, Shandong Province, China
    4Department of Neonatology, Maternity and Child Health Care of Zaozhuang, Zaozhuang 261031, Shandong Province, China
  • Received:2021-12-11 Revised:2022-06-08 Published:2022-08-01
  • Corresponding author: Yan Liu
  • Supported by:
    Shandong Provincial Medical Health Technology Development Project(2016WS0267)
引用本文:

刘燕, 赵铭, 姜红, 陈晨, 王小琴, 张磊. 极早产儿支气管肺发育不良影响因素的多中心临床研究[J/OL]. 中华妇幼临床医学杂志(电子版), 2022, 18(04): 419-426.

Yan Liu, Ming Zhao, Hong Jiang, Chen Chen, Xiaoqin Wang, Lei Zhang. Risk factors of bronchopulmonary dysplasia in very preterm infants: a multicenter study[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2022, 18(04): 419-426.

目的

探讨极早产儿发生支气管肺发育不良(BPD)的影响因素。

方法

选择2020年1月1日至12月31日,于青岛大学附属医院、青岛市市立医院、济宁市第一人民医院及枣庄市妇幼保健院出生并接受治疗的208例极早产儿为研究对象。根据是否发生BPD,将其分为BPD组(n=153)和非BPD组(n=55);再根据BPD严重程度分度,将BPD组极早产儿分为Ⅰ度BPD亚组(n=31)、Ⅱ度BPD亚组(n=17)及Ⅲ度BPD亚组(n=7)。采用回顾性分析法,统计学比较BPD组与非BPD组,以及3个BPD亚组极早产儿出生与治疗情况、生后14 d内液体摄入量等。采用多因素非条件logistic回归分析,探讨极早产儿发生BPD及BPD极早产儿发生Ⅲ度BPD的影响因素。本研究经青岛大学附属医院医学伦理委员会批准(审批文号:QYFYWZLL26841),并且与所有患儿监护人签署临床研究知情同意书。

结果

①BPD组极早产儿出生胎龄、体重、头围及身长,以及生后1、5、10 min Apgar评分,均小于、轻于、短于、低于非BPD组;而孕母产前激素使用率,极早产儿出生窒息率、肺表面活性剂(PS)使用率及早发型败血症(EOS)发生率,以及有创及无创机械通气时间,均高于、长于非BPD组,并且差异均有统计学意义(P<0.05)。②BPD组极早产儿生后第2、4、5、7、11、12天的总液体摄入量,以及生后第6、8~14天肠外液体静脉输注量,均多于非BPD组;生后第1~14天肠内液体摄入量,则均少于非BPD组,并且上述差异均有统计学意义(P<0.05)。③多因素非条件logistic回归分析:极早产儿生后1 min Apgar评分低(OR=1.866,95%CI:1.063~3.274,P=0.030),有创机械通气时间长(OR=1.834,95%CI:1.158~2.905,P=0.010),无创机械通气时间长(OR=1.163,95%CI:1.067~1.267,P=0.001),发生EOS(OR=0.071,95%CI:0.011~0.465,P=0.006)是极早产儿发生BPD的独立危险因素;生后第3、4、5天肠内液体摄入量多(OR=0.671、0.708、0.746,95%CI:0.483~0.932、0.511~0.846、0.583~0.955,P=0.017、0.004、0.020),是极早产儿发生BPD的独立保护因素。④3个BPD亚组极早产儿出生胎龄、孕母产前激素使用率、出生窒息率、EOS发生率及有创机械通气时间,生后第1、2、4、5、6天总液体摄入量及肠外液体静脉输注量,以及生后第1天肠内液体摄入量比较,差异均有统计学意义(均为P<0.05)。但是,这16项因素均不是BPD极早产儿发生Ⅲ度BPD的独立影响因素。

结论

极早产儿发生BPD是多种因素共同作用的结果,减少出生窒息及EOS发生率,优化呼吸支持策略,增加生后第3~5天肠内液体摄入量,有望降低极早产儿BPD发生率。

Objective

To explore influencing factors of bronchopulmonary dysplasia (BPD) in very premature infants.

Methods

From 1 January to 31 December 2020, a total of 208 very premature infants who were born and treated in the Affiliated Hospital of Qingdao University, Jining No.1 People′s Hospital, Qingdao Municipal Hospital and Maternity and Child Health Care of Zaozhuang, were chosen as research subjects. According to whether BPD occurred or not, they were divided into BPD group (n=153) and non-BPD group (n=55). Then according to severity degree of BPD, very premature infants in BPD group were divided into grade Ⅰ BPD subgroup (n=31), grade Ⅱ BPD subgroup (n=17) and grade Ⅲ BPD subgroup (n=7). Clinical data of 208 very premature infants were retrospectively analyzed. Conditions at birth and of treatment, and fluid intake within 14 d after birth of very premature infants were statistically compared between BPD and non-BPD groups, and among 3 BPD subgroups. Multivariate unconditional logistic regression analysis was used to investigate the influencing factors of BPD occurence in very premature infants and grade Ⅲ BPD occurence in BPD very premature infants. This study was approved by the Medical Ethics Committee of the Affiliated Hospital of Qingdao University (Approval No. QYFYWZll26841). All the guardians of the infants signed the informed consents of clinical study.

Results

① The gestational age, weight, head circumference and body length at birth, and 1, 5, 10 min Apgar scores of very premature infants in BPD group were smaller, lighter, shorter, lower than those in non-BPD group; while the usage of prenatal hormones to mother, the incidence of birth asphyxia, usage of pulmonary surfactant (PS), incidence of early onset sepsis (EOS), usage time of invasive and non-invasive ventilation of very premature infants, were higher or longer than those in non-BPD group. And the above differences were statistically significant (P<0.05). ② The total fluid intake at 2, 4, 5, 7, 11, 12 d after birth, and intravenous infusion volume of parenteral fluid at 6 d, 8-14 d after birth of very premature infants in BPD group were more than those in non-BPD group; while the enteral fluid intake at 1-14 d after birth were less than those in non-BPD group. And the above differences were statistically significant (P<0.05). ③ Multivariate unconditional logistic regression analysis showed that lower 1 min Apgar score (OR=1.866, 95%CI: 1.063-3.274, P=0.030), longer duration of invasive ventilation (OR=1.834, 95%CI: 1.158-2.905, P=0.010), longer duration of non-invasive ventilation (OR=1.163, 95%CI: 1.067-1.267, P=0.001), EOS occurence (OR=0.071, 95%CI: 0.011-0.465, P=0.006) were independent risk factors of BPD occurrence in very premature infants. The larger volume of enteral fluid intake at 3, 4, 5 d after birth (OR=0.671, 0.708, 0.746; 95%CI: 0.483-0.932, 0.511-0.846, 0.583-0.955; P=0.017, 0.004, 0.020) were independent protective factors of BPD occurrence in very premature infants. ④ There were significant differences among grade Ⅰ, Ⅱ and Ⅲ BPD subgroups in gestational age at birth, prenatal hormone application to mother, birth asphyxia rate, incidence of EOS and duration of invasive mechanical ventilation, also in total fluid intake and intravenous infusion volume of parenteral fluid at 1, 2, 4, 5, 6 d after birth, and enteral fluid intake at 1 d after birth (all P<0.05). However, these 16 indicators were not independent influencing factors of grade Ⅲ BPD occurrence in BPD very premature infants.

Conclusions

The occurrence of BPD in very premature infants is the result of multiple factors. Reducing incidence of birth asphyxia and EOS, optimizing respiratory support strategies, and increasing enteral fluid intake at 3-5 d after birth, would be expected to reduce incidence of BPD in very premature infants.

表1 BPD与非BPD组极早产儿一般临床资料及治疗情况比较
组别 例数 出生胎龄(周,±s) 男性[例数(%)] BW(g,±s) 出生头围[cm,M(Q1Q3)] 出生身长[cm,M(Q1Q3)] 生后1 min Apgar评分[分,M(Q1Q3)] 生后5 min Apgar评分[分,M(Q1Q3)]
BPD组 55 29.5±1.7 32(58.2) 1 198±279 28(26,29) 37(35,40) 8(5,9) 9(7,9)
非BPD组 153 31.1±1.6 95(62.1) 1 467±283 28(29,30) 40(38,42) 9(7,10) 10(8,10)
统计量   t=6.446 χ2=0.209 t=6.143 Z=-4.445 Z=-5.424 Z=-3.280 Z=-4.044
P   <0.001 0.672 <0.001 <0.001 <0.001 0.001 <0.001
组别 例数 生后10 min Apgar评分[分,M(Q1Q3)] 合并PDA[例数(%)] 小于胎龄儿[例数(%)] 剖宫产娩出[例数(%)] 多胎儿[例数(%)] 孕母胎膜早破[例数(%)] 孕母产前使用激素[例数(%)]
BPD组 55 9(9,10) 15(27.3) 8(14.6) 42(76.4) 8(14.6) 16(29.1) 31(58.5)
非BPD组 153 10(9,10) 41(26.8) 13(8.5) 116(75.8) 35(22.9) 41(26.8) 59(38.6)
统计量   Z=-4.286 χ2=0.005 χ2=1.631 χ2=0.007 χ2=1.712 χ2=0.107 χ2=5.223
P   <0.001 0.946 0.202 0.935 0.191 0.744 0.022
组别 例数 出生窒息[例数(%)] 孕母妊娠期高血压疾病[例数(%)] 孕母妊娠期糖尿病[例数(%)] 使用PS[例数(%)] 发生EOS[例数(%)] 有创机械通气时间(d,±s) 无创机械通气时间(d,±s)
BPD组 55 21(39.6) 14(26.4) 7(13.2) 35(63.6) 23(43.4) 8.89±1.21 25.1±3.7
非BPD组 153 24(15.7) 40(26.1) 34(22.2) 39(25.5) 37(24.2) 0.36±0.15 10.8±2.4
统计量   χ2=12.076 χ2=0.010 χ2=2.305 χ2=25.685 χ2=6.130 t=-85.743 t=-32.580
P   0.001 0.920 0.129 <0.001 0.013 <0.001 <0.001
图1 BPD与非BPD组极早产儿生后14 d内液体摄入量比较(图1A:每日液体总摄入量;图1B:每日肠外液体静脉输注量;图1C:每日肠内液体摄入量)注:a表示BPD与非BPD组比较,P<0.05。BPD为支气管肺发育不良
表2 极早产儿发生BPD的多因素非条件logistic回归分析结果a
表3 3个BPD亚组极早产儿一般临床资料及治疗情况比较
图2 3个BPD亚组极早产儿生后14 d内液体摄入量比较(图2A:每日液体总摄入量;图2B:每日肠外液体静脉输注量;图2C:每日肠内液体摄入量)注:a表示3个BPD亚组比较的P<0.05。BPD为支气管肺发育不良
[1]
Gilfillan M, Bhandari A, Bhandari V. Diagnosis and management of bronchopulmonary dysplasia[J]. BMJ, 2021, 375: n1974. DOI: 10.1136/bmj.n1974.
[2]
Mowitz ME, Gao W, Sipsma H, et al. Long-term burden of respiratory complications associated with extreme prematurity: an analysis of US Medicaid claims[J]. Pediatr Neonatol, 2022: S1875-9572(22)00118-8. DOI: 10.1016/j.pedneo.2022.05.007.
[3]
Higgins RD, Jobe AH, Koso-Thomas M, et al. Bronchopulmonary dysplasia: executive summary of a workshop[J]. J Pediatr, 2018, 197: 300-308. DOI: 10.1016/j.jpeds.2018.01.043.
[4]
山东省多中心NICU早产儿入院低体温质量改进临床研究协作组. 基于证据的质量改进方法降低极低出生体重儿入院低体温发生率的多中心研究方案[J]. 中国循证儿科杂志2019, 14(2): 139-142. DOI: 10.3969/j.issn.1673-5501.2019.02.012.
[5]
Sriram S, Schreiber MD, Msall ME, et al. Cognitive development and quality of life associated with bpd in 10-year-olds born preterm[J]. Pediatrics, 2018, 141(6): e20172719. DOI: 10.1542/peds.2017-2719.
[6]
Shukla VV, Ambalavanan N. Recent advances in bronchopulmonary dysplasia[J]. Indian J Pediatr, 2021, 88(7): 690-695. DOI: 10.1007/s12098-021-03766-w.
[7]
Malikiwi AI, Lee YM, Davies-Tuck M, et al. Postnatal nutritional deficit is an independent predictor of bronchopulmonary dysplasia among extremely premature infants born at or less than 28 weeks gestation[J]. Early Hum Dev, 2019, 131: 29-35. DOI: 10.1016/j.earlhumdev.2019.02.005.
[8]
吴怡玲,芦惠,张志群. 营养与支气管肺发育不良关系研究进展[J]. 中华新生儿科杂志(中英文), 2020, 35(2): 148-152. DOI: 10.3760/cma.j.issn.2096-2932.2020.02.019.
[9]
Muehlbacher T, Bassler D, Bryant MB. Evidence for the management of bronchopulmonary dysplasia in very preterm infants[J]. Children (Basel), 2021, 8(4): 298. DOI: 10.3390/children8040298.
[10]
Rocha G, Guimarães H, Pereira-da-Silva L. The role of nutrition in the prevention and management of bronchopulmonary dysplasia: a literature review and clinical approach[J]. Int J Environ Res Public Health, 2021, 18(12): 6245. DOI: 10.3390/ijerph18126245.
[11]
卢庆晖,东方,张松青,等. 支气管肺发育不良极低出生体重早产儿生后4天内液体摄入量和中心静脉压特点分析[J]. 中华新生儿科杂志(中英文), 2020, 35(2): 123-126. DOI: 10.3760/cma.j.issn.2096-2932.2020.02.011.
[12]
Barrington KJ, Fortin-Pellerin E, Pennaforte T. Fluid restriction for treatment of preterm infants with chronic lung disease[J]. Cochrane Database Syst Rev, 2017, 2(2): CD005389. DOI: 10.1002/14651858.CD005389.pub2.
[13]
Bell EF, Acarregui MJ. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants[J]. Cochrane Database Syst Rev, 2014, 2014(12): CD000503. DOI: 10.1002/14651858.CD000503.pub3.
[14]
Al-Jebawi Y, Agarwal N, Groh Wargo S, et al. Low caloric intake and high fluid intake during the first week of life are associated with the severity of bronchopulmonary dysplasia in extremely low birth weight infants[J]. J Neonatal Perinatal Med, 2020, 13(2): 207-214. DOI: 10.3233/NPM-190267.
[15]
Oh W, Poindexter BB, Perritt R, et al. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants[J]. J Pediatr, 2005, 147(6): 786-790. DOI: 10.1016/j.jpeds.2005.06.039.
[16]
Jochum F, Moltu SJ, Senterre T, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: fluid and electrolytes[J]. Clin Nutr, 2018, 37(6 Pt B): 2344-2353. DOI: 10.1016/j.clnu.2018.06.948.
[17]
Eibensteiner F, Laml-Wallner G, Thanhaeuser M, et al. ELBW infants receive inadvertent sodium load above the recommended intake[J]. Pediatr Res, 2020, 88(3): 412-420. DOI: 10.1038/s41390-020-0867-9.
[18]
Kim SB, Lee JH, Lee J, et al. The efficacy and safety of montelukast sodium in the prevention of bronchopulmonary dysplasia[J]. Korean J Pediatr, 2015, 58(9): 347-353. DOI: 10.3345/kjp.2015.58.9.347.
[19]
Soullane S, Patel S, Claveau M, et al. Fluid status in the first 10 days of life and death/bronchopulmonary dysplasia among preterm infants[J]. Pediatr Res, 2021, 90(2): 353-358. DOI: 10.1038/s41390-021-01485-8.
[1] 明昊, 肖迎聪, 巨艳, 宋宏萍. 乳腺癌风险预测模型的研究现状[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 287-291.
[2] 庄燕, 戴林峰, 张海东, 陈秋华, 聂清芳. 脓毒症患者早期生存影响因素及Cox 风险预测模型构建[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 372-378.
[3] 黄鸿初, 黄美容, 温丽红. 血液系统恶性肿瘤患者化疗后粒细胞缺乏感染的危险因素和风险预测模型[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 285-292.
[4] 罗文斌, 韩玮. 胰腺癌患者首次化疗后中重度骨髓抑制的相关危险因素分析及预测模型构建[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 357-362.
[5] 贺斌, 马晋峰. 胃癌脾门淋巴结转移危险因素[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 694-699.
[6] 林凯, 潘勇, 赵高平, 杨春. 造口还纳术后切口疝的危险因素分析与预防策略[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 634-638.
[7] 杨闯, 马雪. 腹壁疝术后感染的危险因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 693-696.
[8] 周艳, 李盈, 周小兵, 程发辉, 何恒正. 不同类型补片联合Nissen 胃底折叠术修补食管裂孔疝的疗效及复发潜在危险因素[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 528-533.
[9] 周劲鸿, 王鉴杰, 谢肖俊. 腹腔镜经腹腹膜前疝修补术后尿潴留发生率及危险因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(04): 390-395.
[10] 张伟伟, 陈启, 翁和语, 黄亮. 随机森林模型预测T1 期结直肠癌淋巴结转移的初步研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 389-393.
[11] 司楠, 孙洪涛. 创伤性脑损伤后肾功能障碍危险因素的研究进展[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 300-305.
[12] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
[13] 李文哲, 王毅, 崔建, 郑启航, 王靖彦, 于湘友. 新疆维吾尔自治区重症患者急性肾功能异常的危险因素分析[J/OL]. 中华卫生应急电子杂志, 2024, 10(05): 269-276.
[14] 刘志超, 胡风云, 温春丽. 山西省脑卒中危险因素与地域的相关性分析[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 424-433.
[15] 曹亚丽, 高雨萌, 张英谦, 李博, 杜军保, 金红芳. 儿童坐位不耐受的临床进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 510-515.
阅读次数
全文


摘要